Would prostate cancer detected by screening withprostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden-Reference-Cited by-同舟云学术

Would prostate cancer detected by screening withprostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden

Published:2000-09 Issue:9 Volume:85 Page:1078-1084
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Hugosson J.,Aus G.,Becker C.,Carlsson S.,Eriksson H.,Lilja H.,Lodding P.,Tibblin G.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1464-410x.2000.00679.x/fullpdf

Reference28 articles.

1. Defining and updating the American Cancer Society guidelines for cancer-related check-up: prostate and endometrial cancers;Mettlin;CA Cancer J Clin,1993

2. Surveillance is not viable and appropriate treatment option in the management of localized carcinoma of the prostate;Hugosson;Urol Clin North Am,1996

3. Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent;Aus;J Urol,1995

4. The burden of prostate cancer from diagnosis until death;Otnes;Br J Urol,1995

5. The cost of prostatic cancer in a defined population;Carlsson;Scand J Urol Nephrol,1989

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate‐specific antigen screening in 2012;Cancer;2019-12-03

2. “Reverse Stage Migration”: What Can Population-based Data Tell Us About Trends in Prostate Cancer Presentation?;European Urology Oncology;2018-09

3. Will New Genetic Techniques Like Exome Sequencing Obviate the Need for Clinical Expertise? No;Movement Disorders Clinical Practice;2016-10-17

4. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial;European Urology;2016-10

5. Life expectancy estimates as a key factor in over-treatment: The case of prostate cancer;Cancer Epidemiology;2013-08